Jezabel Rodriguez-Blanco (Jezabel Rodríguez-Blanco)

Scopus Author ID ResearcherID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 3

Top Topics

Signaling Pathway

Top Venues

Molecular cancer research : MCR

Science advances

Journal of cellular physiology

Medical University of South Carolina

University of Oviedo (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

Medical University of South Carolina Jan 02 2020

United States

Assistant Professor :: Pediatrics

University of Miami Oct 01 2016 - Dec 31 2019

United States

Assistant Scientist :: Surgery

University of Miami Mar 10 2010 - Sep 30 2016

United States

Postdoctoral Associate :: Surgery

Columbia University Columbia College Jun 28 2009 - Dec 18 2009

United States

Postdoctoral Fellow :: Pathology

Education History

University of Oviedo

Spain

PHD :: Morphology and Cell biology Dpt

University of Oviedo

Spain

BSC

Publications

Marzena Swiderska-Syn, Júlia Mir-Pedrol, Alexander Oles, Olga Schleuger, April D Salvador, Sean M Greiner, Cara Seward, Fan Yang, Benjamin R Babcock, Chen Shen, Daniel T Wynn, Avencia Sanchez-Mejias, Timothy R Gershon, Vanesa Martin, Heather J McCrea, Kathryn G Lindsey, Carsten Krieg, Jezabel Rodriguez-Blanco
Noncanonical activation of GLI signaling in SOX2 + cells drives medulloblastoma relapse. Science advances 8 (29) (2022)
Fan Yang, Jezabel Rodriguez-Blanco, Jun Long, Marzena Swiderska-Syn, Daniel T Wynn, Bin Li, Chen Shen, Anmada Nayak, Yuguang J Ban, Xiaodian Sun, Robert K Suter, Heather J McCrea, Anthony J Capobianco, Nagi G Ayad, David J Robbins
A Druggable UHRF1/DNMT1/GLI Complex Regulates Sonic Hedgehog-Dependent Tumor Growth. Molecular cancer research : MCR 20 (11) (2022)
Carmen Rodríguez, Noelia Puente-Moncada, Russel Joseph Reiter, Ana M Sánchez-Sánchez, Federico Herrera, Jezabel Rodriguez-Blanco, Cristina Duarte-Olivenza, María Turos-Cabal, Isaac Antolín, Vanesa Martín
Regulation of cancer cell glucose metabolism is determinant for cancer cell fate after melatonin administration. Journal of cellular physiology 236 (1) (2020)